HCYT
Price:
$0.995
Market Cap:
$624.98K
H-CYTE, Inc., a biopharmaceutical company, develops and delivers various treatments for patients with chronic respiratory and pulmonary disorders in the United States. The company develops and implements treatment options in autologous cellular therapy to treat chronic lung disorders. It has a product supply agreement with Rion, LLC to develop and distribute a biologic for chronic obstructive pulmonary disease. The company is headquartered in Tampa, Florida.[Read more]
Industry
Biotechnology
IPO Date
2014-12-19
Stock Exchange
PNK
Ticker
HCYT
According to H-CYTE, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 4.52M. This represents a change of -36.88% compared to the average of 7.16M of the last 4 quarters.
The mean historical Enterprise Value of H-CYTE, Inc. over the last ten years is 17.69M. The current 4.52M Enterprise Value has changed 2.45% with respect to the historical average. Over the past ten years (40 quarters), HCYT's Enterprise Value was at its highest in in the December 2014 quarter at 24.17B. The Enterprise Value was at its lowest in in the December 2020 quarter at 1.35M.
Average
17.69M
Median
11.67M
Minimum
1.35M
Maximum
51.05M
Discovering the peaks and valleys of H-CYTE, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 776.32%
Maximum Annual Enterprise Value = 51.05M
Minimum Annual Increase = -90.37%
Minimum Annual Enterprise Value = 1.35M
Year | Enterprise Value | Change |
---|---|---|
2022 | 8.31M | -29.70% |
2021 | 11.82M | 776.32% |
2020 | 1.35M | -90.37% |
2019 | 14.00M | 41.17% |
2018 | 9.92M | -8.50% |
2017 | 10.84M | -39.56% |
2016 | 17.93M | 55.64% |
2015 | 11.52M | -71.36% |
2014 | 40.22M | -21.21% |
The current Enterprise Value of H-CYTE, Inc. (HCYT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
7.16M
5-year avg
9.08M
10-year avg
17.69M
H-CYTE, Inc.’s Enterprise Value is greater than Algernon Pharmaceuticals Inc. (1.30M), less than Adynxx, Inc. (0), greater than Ascletis Pharma Inc. (581.00), less than BioCardia, Inc. (964.60M), less than Genelux Corporation (7.63M), less than Comera Life Sciences Holdings, Inc. (95.54M), greater than Dyadic International, Inc. (-1593200.00), less than Cingulate Inc. (33.04M), greater than Monopar Therapeutics Inc. (-9795411747.00), greater than Wesana Health Holdings Inc. (-5933276068.00), greater than BioVaxys Technology Corp. (321.05K), less than GH Research PLC (19.71M), less than AXIM Biotechnologies, Inc. (361.59M), less than Aura Biosciences, Inc. (7.61M), less than Axcella Health Inc. (528.67M), greater than Bavarian Nordic A/S (-7493000.00), less than Antibe Therapeutics Inc. (15.51B), less than null (4.59M),
Company | Enterprise Value | Market cap |
---|---|---|
1.30M | $1.37M | |
0 | $581.00 | |
581.00 | $182.17M | |
964.60M | $10.12K | |
7.63M | $101.19M | |
95.54M | $3.07K | |
-1593200.00 | $33.60M | |
33.04M | $10.56M | |
-9795411747.00 | $86.81M | |
-5933276068.00 | $134.12K | |
321.05K | $14.47M | |
19.71M | $447.96M | |
361.59M | $1.21M | |
7.61M | $539.71M | |
528.67M | $0 | |
-7493000.00 | $2.33B | |
15.51B | $11.45M | |
4.59M | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like H-CYTE, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like H-CYTE, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is H-CYTE, Inc.'s Enterprise Value?
What is the highest Enterprise Value for H-CYTE, Inc. (HCYT)?
What is the 3-year average Enterprise Value for H-CYTE, Inc. (HCYT)?
What is the 5-year average Enterprise Value for H-CYTE, Inc. (HCYT)?
How does the current Enterprise Value for H-CYTE, Inc. (HCYT) compare to its historical average?